lactobacillu
casei
atcc
select
bacteri
carrier
develop
mucos
vaccin
porcin
parvoviru
ppv
infect
ppv
major
structur
polypeptid
use
model
parvoviru
antigen
two
induc
express
system
name
cellsurfac
express
system
secret
express
system
base
xylos
operon
promot
use
express
protein
immunogen
recombin
strain
produc
protein
two
cellular
locat
cellsurfac
expos
secret
compar
immun
mice
intragastr
administr
two
type
construct
abl
induc
strong
specif
immun
respons
via
intragastr
administr
maximum
titr
iga
igg
attain
day
post
oral
immun
highest
antibodi
level
obtain
strain
produc
protein
extracellular
milieu
induc
antibodi
demonstr
neutral
effect
ppv
infect
clear
gastrointestin
mucosa
primari
site
natur
viru
transmiss
also
serv
reservoir
viru
infect
persist
although
parenter
vaccin
usual
effect
elicit
protect
immun
respons
respons
desir
viru
enter
bodi
via
mucos
surfac
mucosacentr
natur
viru
infect
provid
strong
rational
develop
mucos
vaccin
induc
suffici
mucos
respons
prevent
viru
establish
mucosa
site
continu
replic
dissemin
tissu
furthermor
studi
suggest
vaccin
induc
local
mucos
immun
particular
induct
local
cytotox
lymphocyt
ctl
may
control
viral
replic
within
local
tissu
prior
system
dissemin
result
also
provid
strong
support
develop
new
gener
vaccin
induc
mucos
secretori
immunoglobulin
iga
viru
porcin
parvoviru
ppv
autonom
parvoviru
major
caus
reproduct
failur
swine
result
earli
embryon
death
fetal
death
stillbirth
delay
return
oestru
viral
genom
consist
linear
minuspolar
singlestrand
kb
dna
construct
three
structur
polypeptid
mw
respect
structur
polypeptid
encompass
major
antigen
domain
could
induc
neutral
antibodi
neutral
ppv
infect
like
mani
pathogen
ppv
initi
infecti
cycl
mucos
surfac
especi
intestin
mucos
epitheli
surfac
effici
protect
mucos
infect
requir
develop
new
vaccin
induc
protect
immun
respons
system
level
also
mucos
level
order
prevent
reduc
dissemin
viru
mucosa
best
achiev
mucos
vaccin
rout
offer
sever
advantag
tradit
parenter
vaccin
howev
local
administr
pure
antigen
subunit
vaccin
usual
rather
ineffici
sever
strategi
develop
deliv
antigen
immunogen
protect
form
target
mucosa
one
promis
approach
reli
use
live
bacteri
vehicl
potenti
develop
lactic
acid
bacteria
lab
deliv
heterolog
antigen
mucos
immun
x
u
yigang
l
yije
system
propos
mani
properti
make
attract
candid
antigen
deliveri
carrier
present
mucosa
compound
pharmaceut
interest
particular
vaccin
exampl
lab
long
use
industri
food
ferment
preserv
known
benefici
effect
health
human
anim
consid
gener
regard
safe
gra
microorgan
addit
mani
strain
lab
abl
surviv
colon
intestin
tract
induc
nonspecif
immunoadjuv
effect
provok
serial
studi
aim
determin
capabl
feasibl
applic
lab
safe
oral
vaccin
therefor
develop
effici
gene
express
protein
secret
system
nonpathogen
gramposit
lab
new
strategi
parvoviru
vaccin
studi
chose
develop
lactobacillu
casei
antigendeliveri
carrier
oral
vaccin
ppv
construct
recombin
strain
produc
parvoviru
model
antigen
structur
polypeptid
two
cellular
locat
extern
milieu
anchor
cell
surfac
use
plasmid
differ
target
immunogen
two
recombin
strain
analys
intragastr
administr
live
bacteria
mice
data
indic
intragastr
intub
two
recombin
strain
could
induc
specif
mucos
system
immun
respons
ppv
higher
specif
immun
respons
obtain
recombin
strain
produc
extracellular
milieu
bacteri
strain
growth
condit
lactobacillu
casei
atcc
kindli
suppli
jo
seeger
nizo
holland
grown
mann
rogosa
sharp
mr
medium
sigma
st
loui
mo
naerob
without
shake
analysi
express
protein
recombin
strain
grown
basal
mr
medium
supplement
xylos
antibiot
concentr
use
select
transform
lgml
chloromycetin
cm
sigma
express
plasmid
type
secret
express
vector
contain
ssusp
secret
signal
peptid
sequenc
express
plasmid
type
cellsurfac
express
plasmid
contain
structur
ssusp
secret
signal
sequenc
cell
wall
anchor
domain
kindli
suppli
jo
seeger
nizo
holland
nucleic
acid
manipul
clone
procedur
perform
accord
standard
procedur
gene
fragment
kb
encod
structur
polypeptid
ppv
obtain
genom
ppv
strain
polymeras
chain
reaction
pcr
amplif
primer
cgaggatcc
forward
contain
bamhi
site
underlin
agctt
revers
contain
xhoi
site
underlin
pcr
amplif
condit
follow
min
cycl
min
min
min
min
final
extens
pcr
product
gene
cleav
bamhi
xhoi
restrict
endonucleas
mbi
insert
correspond
site
digest
bamhi
xhoi
respect
give
rise
fig
electropor
l
casei
carri
previous
describ
modif
brief
recombin
plasmid
dna
ad
l
casei
gentli
mix
min
subject
singl
electr
puls
lf
kvcm
mixer
incub
mr
medium
without
cm
hr
recombin
strain
select
mrsagar
medium
contain
lgml
cm
presenc
integr
construct
carri
l
casei
transform
check
extract
recombin
plasmid
dna
follow
restrict
analysi
sequenc
analys
express
fusion
protein
xyloseinduc
grown
basal
mr
medium
supplement
xylos
collect
centrifug
g
min
pellet
wash
twice
steril
mm
triscl
ph
lyse
beadbeat
biospec
bartlesvil
ok
vigor
shake
lysat
centrifug
g
min
supern
examin
use
sodium
dodecyl
sulphatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
analysi
protein
electrotransf
onto
nitrocellulos
membran
immunoblot
develop
use
mous
serum
dilut
phosphatebuff
salin
pb
horseradish
peroxidas
hrp
conjug
goat
antimous
igg
sigma
dilut
use
visual
immunolabel
band
carri
use
chemiluminesc
substrat
reagent
pierc
rockford
il
accord
manufactur
instruct
assay
local
fusion
protein
cell
treat
mgml
lysozym
min
centrifug
supern
maintain
analysi
parallel
experi
cell
treat
mgml
proteas
sigma
hr
wash
thrice
remov
proteas
treat
lysozym
bacteri
protein
extract
supern
analys
use
western
blot
previous
describ
immunofluoresc
also
use
analys
surfac
express
protein
carri
previous
describ
brief
ml
induc
cultur
harvest
od
resuspend
ml
steril
bovin
serum
albumin
bsa
contain
antibodi
incub
overnight
cell
pellet
wash
thrice
steril
remov
noncombin
antibodi
cellantibodi
complex
incub
hr
avoid
light
exposur
fluoreoscein
isothiocyan
fitc
conjug
goat
antimous
igg
sigma
contain
evan
blue
cell
wash
thrice
laid
glass
slide
airdri
analysi
perform
confoc
microscopi
noninduc
recombin
strain
use
neg
control
analys
secret
express
overnight
cultur
grown
basal
mr
medium
supplement
xylos
collect
centrifug
g
min
centrifug
supern
concentr
time
use
centrifug
filter
unit
millipor
billerica
concentr
supern
examin
use
sdspage
western
blot
previous
describ
immun
sevenweekold
balbc
mice
use
anim
model
free
access
standard
mous
diet
water
cultur
centrifug
cell
pellet
wash
steril
pb
resuspend
pb
ph
concentr
colonyform
unit
cfu
ml
vaccin
group
mice
receiv
dose
cell
two
recombin
strain
respect
group
mice
immun
equival
dose
l
casei
l
casei
contain
empti
plasmid
receiv
pb
use
control
mice
immun
via
oral
rout
immun
protocol
administ
three
consecut
day
day
booster
immun
given
day
second
booster
given
day
enzymelink
immunosorb
assay
elisa
analysi
sera
mice
collect
day
first
immun
store
requir
intestin
mucu
mice
extract
describ
previous
elisa
analysi
polystyren
microtitr
plate
coat
overnight
full
ppv
viru
propag
st
cell
cultur
st
cell
use
neg
control
antigen
elisa
plate
wash
thrice
satur
pb
contain
skim
milk
hr
serum
intestin
lavag
serial
dilut
bsa
use
primari
antibodi
incub
hr
plate
wash
thrice
bound
antibodi
detect
use
hrpconjug
goat
antimous
iga
sigma
igg
sigma
dilut
follow
colour
develop
use
ophenylen
diamin
dihydrochlorid
sigma
substrat
absorb
measur
nm
intestin
fluid
serum
sampl
mice
immun
two
kind
recombin
strain
express
evalu
use
plaqu
reduct
assay
determin
neutral
abil
induc
antibodi
accord
method
describ
ps
ho
et
al
brief
lavag
sera
nonexpressor
strain
pb
fed
mice
use
neg
control
fifti
microlitr
sampl
twofold
serial
dilut
prepar
microcentrifug
tube
ppv
adjust
tcid
viru
diluent
ad
tube
contain
serial
dilut
serum
intestin
lavag
antibodi
viru
mixtur
mix
puls
centrifug
incub
hr
plate
confluent
monolay
swine
testicular
st
cell
use
viru
infect
inocul
antibodyviru
mixtur
anoth
hr
rock
min
interv
inoculum
remov
overlay
medium
equal
volum
concentr
cell
cultur
medium
plate
incub
co
incub
day
overlay
medium
discard
well
wash
thrice
steril
pb
ph
stain
crystal
violet
solut
differ
number
plaqu
form
treatment
examin
level
signific
student
ttest
analysi
varianc
overnight
cultur
grown
basal
mr
medium
supplement
either
xylos
glucos
collect
cell
lysat
analys
sdspage
western
blot
coomassi
blue
gel
stain
show
express
mw
fusion
protein
lysat
induc
xylos
fig
lane
cell
grown
glucos
fig
lane
wildtyp
l
casei
grown
xylos
fig
lane
western
blot
analysi
show
immunoreact
band
detect
fig
lane
similar
posit
observ
sdspage
shown
fig
recombin
strain
grown
mr
medium
contain
glucos
fig
lane
wild
type
l
casei
grown
mr
medium
contain
xylos
fig
lane
result
show
xylos
promot
l
casei
use
effici
induc
express
ppv
heterolog
protein
local
analysi
protein
xyloseinduc
via
western
blot
show
induc
treat
lysozym
mw
band
releas
supern
fig
lane
similar
posit
observ
cell
lyse
beadbeat
fig
lane
could
detect
supern
cell
treat
proteas
data
shown
treatment
proteas
previou
lysozym
give
singl
band
mw
fig
lane
none
band
observ
supern
untreat
cell
fig
lane
immunofluoresc
reaction
induc
xylos
develop
mous
serum
fluorescein
isothiocyan
fitc
conjug
goat
antimous
igg
also
show
greenyellow
fluoresc
cell
surfac
grown
xylos
fig
glucos
recombin
strain
red
dy
evan
blue
fig
result
suggest
protein
could
display
cell
surfac
fragment
protein
appear
embed
cell
wall
fig
lane
glucos
fig
lane
immunoreact
band
mw
detect
supern
induc
xylos
fig
lane
wherea
band
control
lane
supern
grown
glucos
fig
lane
immunogen
two
recombin
strain
evalu
intragastr
administr
mice
local
immun
respons
studi
measur
siga
level
intestin
lavag
post
intragastr
immun
concentr
mucos
siga
antibodi
express
titr
determin
express
test
sampl
standard
curv
gener
serial
dilut
commerci
purchas
iga
sigma
known
titr
result
show
substanti
differ
mucos
siga
level
experiment
group
control
group
prior
intragastr
immun
oral
immun
recombin
strain
express
elicit
antigen
specif
mucos
siga
respons
second
boost
high
level
siga
obtain
intestin
lavag
fig
oral
administr
wherea
antibodi
observ
control
group
mice
use
st
cell
cultur
neg
control
antigen
data
shown
mucos
siga
level
elicit
higher
elicit
statist
signific
differ
observ
day
specif
igg
level
sera
immun
mice
determin
fig
mice
oral
administr
second
boost
elicit
prompter
stronger
igg
level
comparison
mucos
iga
induc
intestin
signific
elicit
antibodi
observ
control
group
mice
use
st
cell
cultur
neg
control
antigen
data
shown
serum
igg
level
elicit
higher
elicit
statist
signific
differ
p
observ
day
serum
igg
respons
induc
intragastr
immun
recombin
strain
sera
group
mice
oral
immun
recombin
strain
express
equival
dose
contain
empti
plasmid
neg
control
sera
mice
receiv
pb
analys
presenc
specif
igg
elisa
use
ppv
coat
antigen
bar
repres
igg
titr
sem
group
plaqu
reduct
assay
perform
detect
whether
antibodi
respons
ppv
result
demonstr
presenc
siga
igg
cultur
medium
confer
statist
signific
neutral
effect
p
ppv
infect
fig
near
reduct
number
plaqu
consist
observ
plaqu
reduct
assay
carri
use
twoto
fourfold
dilut
intestin
lavag
twoto
dilut
sera
mice
immun
signific
differ
final
signific
dilut
antibodi
obtain
mice
immun
fig
fig
b
respect
inhibitori
effect
decreas
gradual
dilut
intestin
lavag
sera
reach
level
similar
control
fig
fig
b
fig
fig
b
neutral
efficaci
iga
igg
mice
immun
lower
antibodi
obtain
mice
immun
fig
infect
ppv
econom
concern
pig
breeder
worldwid
initi
infect
ppv
mainli
occur
mucosa
intestin
critic
step
infect
process
vaccin
main
prophylat
method
prevent
ppv
infect
parenter
vaccin
usual
effect
elicit
system
immun
respons
howev
respons
obtain
prevent
viru
enter
bodi
via
mucos
surfac
therefor
elicit
effici
immun
respons
system
also
mucos
level
highli
desir
vaccin
goal
achiev
vaccin
formul
administ
mucos
rout
great
deal
research
current
focus
develop
adequ
mucos
vaccin
variou
vaccin
deliveri
system
explor
oral
applic
attenu
pseudorabi
viru
carri
protein
ppv
abl
protect
mice
viral
challeng
live
vector
vaccinia
viru
express
ppv
protein
stimul
protect
immun
respons
howev
major
live
vector
potenti
risk
prone
lab
increas
interest
express
heterolog
molecul
absenc
outer
membran
gramposit
microorgan
make
particularli
attract
display
secret
biolog
activ
molecul
date
seri
recombin
lactobacilli
express
heterolog
pathogen
antigen
construct
streptococcu
pneumonia
antigen
psaa
pspa
transmiss
gastroentr
coronaviru
glycoprotein
tetanu
toxin
fragment
c
cholera
toxin
b
subunit
studi
engin
first
time
use
l
casei
express
ppv
main
immun
protect
antigen
protein
two
xyloseinduc
express
system
explor
potenti
valu
oral
vaccin
protein
express
extern
milieu
cell
surfac
respect
whose
good
antigen
properti
could
recogn
antiserum
conduct
control
comparison
immunogen
two
recombin
strain
produc
protein
ppv
extern
milieu
cell
surfac
administr
mice
intragastr
rout
oral
administr
regim
consist
three
set
three
success
daili
dose
recombin
strain
experiment
vaccin
three
success
daili
dose
recombin
bacteria
requir
order
ensur
system
antibodi
respons
ppv
could
elicit
mice
receiv
recombin
strain
intragastr
princip
antibodi
type
involv
mucos
immun
secretori
immunoglobulin
siga
major
releas
gastrointestin
fluid
result
immun
indic
recombin
strain
construct
studi
abl
elicit
mucos
immun
respons
produc
siga
antibodi
system
immun
respons
produc
igg
contrast
express
extern
milieu
induc
much
higher
antibodi
level
local
mucos
system
immun
respons
mice
elicit
display
cell
surfac
statist
signific
differ
observ
day
estim
quantit
immunoblot
analysi
differ
could
relat
vari
level
product
depend
cellular
locat
antigen
therefor
strong
immunogen
probabl
result
high
level
extern
milieu
product
could
effect
react
intestin
mucos
tissu
hypothes
protein
express
may
embed
cell
wall
partli
access
cell
surfac
could
fulli
associ
gut
lymphoid
tissu
result
lower
level
immun
antibodi
induc
furthermor
order
confirm
efficaci
induc
antibodi
inhibit
viru
test
whether
intestin
lavag
sera
collect
immun
mice
could
inhibit
infect
st
cell
plaqu
reduct
neutral
assay
result
show
serum
intestin
sampl
collect
mice
immun
demonstr
statist
signific
inhibit
although
recombin
vector
could
also
induc
neutral
antibodi
neutral
intestin
lavag
antibodi
obtain
mice
immun
recombin
vector
effect
immun
mice
recombin
vector
hand
immun
result
cell
surfac
express
antigen
contrast
publish
shaw
et
al
found
cell
surfac
present
heterolog
antigen
induc
detect
immun
respons
intragastr
rout
sever
factor
may
explain
differ
success
mucos
immun
requir
deliveri
minim
threshold
load
antigen
therefor
possibl
recombin
strain
describ
shaw
et
al
produc
insuffici
antigen
quantiti
cell
surfac
altern
intrins
immunostimulatori
properti
l
casei
atcc
yet
determin
may
differ
l
plantarum
use
shaw
et
al
strain
use
studi
abl
adher
colon
intestin
tract
toler
bile
data
shown
would
render
appropri
oral
vaccin
carrier
probiot
effect
harmless
natur
l
casei
summari
use
method
describ
better
result
ie
high
serum
igg
local
iga
respons
obtain
strain
produc
antigen
extern
milieu
better
immunogen
abl
elicit
high
specif
mucos
system
immun
respons
antigen
would
make
appropri
oral
vaccin
ppv
infect
mechan
secret
antigen
also
abl
transud
intravascular
compart
induc
system
immun
respons
investig
